article thumbnail

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

Pharmaceutical Technology

XtalPi has entered a strategic partnership with CK Life Sciences for artificial intelligence (AI)-driven tumour vaccine research and development (R&D). The platform could potentially forecast and design several tumour vaccines that can trigger certain immune responses to fight tumours.

article thumbnail

World Pneumonia Day 2024: New Treatments and Innovations

XTalks

World Pneumonia Day 2024 provides an opportunity to examine the latest advances in pneumonia treatment and prevention — and the role that healthcare and life sciences industries play in reducing its global impact. These therapies work by controlling excessive inflammatory responses in the lungs.

Bacteria 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BioLink receives funds to develop Covid-19 pneumonia treatment

Pharmaceutical Technology

BioLink Life Sciences has received a contract worth $750,000 from the US Biomedical Advanced Research and Development Authority (BARDA) to develop Ramatroban for treating Covid-19 pneumonia patients in the hospital setting. The trial will also lay the ground for additional trials for acute and long Covid in the US.

article thumbnail

2021 Year in Review: Leveraging New Technologies to Drive Innovation in the Life Sciences

XTalks

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year 2021 was all about continuing innovations in the life sciences. Life Science Innovations: Malaria and Influenza Vaccines.

article thumbnail

Novocure’s TTFields Therapy Shows Survival Benefit in Pancreatic Cancer

XTalks

This multifaceted mechanism not only targets the structural integrity of cancer cells but also enhances immune responses and increases tumor permeability to improve the efficacy of other treatments. Novocure’s broader pipeline underscores the versatility of TTFields therapy.

Trials 105
article thumbnail

Social Media’s Disinformation Dozen + Pfizer’s Latest COVID-19 Vaccine Trial Results – Xtalks Life Science Podcast Ep. 5

XTalks

In this episode of the Xtalks Life Science Podcast, Ayesha discusses a report from the Center for Countering Digital Hate (CCDH) and Anti-Vax Watch that shows there are just 12 people behind 65 percent of all online anti-vaccine disinformation. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

article thumbnail

Off-target immune response could predict COVID-19 severity

Scienmag

The presence of special immune system defense molecules, called autoimmune antibodies, has been strongly tied to how poorly people fare when hospitalized with COVID-19, a new study shows.